COVID-19 testing service now available from MDNA's UK laboratory: Click here ›

MDNA Life Sciences and Shuwen Biotech Ink Partnership to Bring the Mitomic® Prostate Test to the Chinese Market

MDNA has appointed Shuwen Biotech Co. Ltd., a leader in developing and offering innovative diagnostic and personalized medicine products in China, as the exclusive license partner for the Mitomic® Prostate Test (MPT™) in China. On the heels of recent news that MDNA’s CE marked MPT™ Real-Time PCR kit is being made available through another 9 business partners covering 25 countries, this agreement is a key part of the global roll-out of MPT™ through a growing network of license partners and distributors.